Syntheses of 4,5-disubstituted oxazoles via regioselective C-4 bromination

Organic Process Research and Development

Volumn 11, Issue 6, 2007, Pages 951-955

  Li, Bryan ^a   Buzon, Richard A ^a   Zhang, Zhijun ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 37049019663     PISSN: 10836160     EISSN: None     Source Type: Journal    
DOI: 10.1021/op700176n     Document Type: Article

References (46)

1. (a) Laszo, R.; Schlapbach, A. PCT Int. Appl. WO 0063204, 2000; Chem. Abst. 133:321897.
2. (b) Lipton, S. A. PCT Int. Appl. WO 0101986, 2001.
3. (c) Andersson, M.; Hansen Peter; L.; Nikitidis, A.; Sjoelin, P. PCT Int. Appl. WO 2005026123, 2005; Chem. Abstr. 142: 316705.
4. (d) Revesz, L.; Blum, E.; Di Padova, F. E.; Buhl, T.; Feifel, R.; Gram, H.; Hiestand, P.; Manning, U.; Rucklin, G. Bioorg. Med. Chem. Lett. 2004, 14, 3595-3599.
5. (e) Blumberg, L. C.; Munchhof, M. J. PCT Int. Appl. WO 2004026863, 2004; Chem. Abstr. 140: 287371.
6. (f) Svenstrup, N.; KuW, A.; Flubacher, D.; Brands, M.; Ehlert, K.; Ladel, C.; Otteneder, M.; Keldenich, J. PCT Int. Appl. WO 2003072574,2003; Chem. Abstr. 139:230786.
7. (g) Alcaraz, L.; Furber, M.; Purdie, M.; Springthorpe, B. PCT Int. Appl. WO 2003068743, 2003; Chem. Abstr. 139:197375.
8. (h) Iwanowicz, E. J.; Watterson, S. H.; Guo, J.; Pitts, W. J.; Murali, D. T. G.; Shen, Z.; Chen, P.; Gu, H. H.; Fleener, C. A.; Rouleau, K. A.; Cheney, D. L.; Townsend, R. M.; Hollenbaugh, D. L. Bioorg. Med. Chem. Lett. 2003, 13, 2059-2063.
9. (i) Varghese, J.; Maillard, M.; Jagodzinska, B.; Beck, J. P.; Gailunas, A.; Fang, L.; Sealy, J.; Tenbrink, R.; Freskos, J.; Mickelson, J.; Samala, L.; Hom, R. PCT Int. Appl. WO 2003040096, 2003; Chem. Abstr. 138:385173.
10. (j) Revesz, L.; Schlapbach, A. PCT Int. Appl. WO 2000063204,2000; Chem. Abstr. 133:321897.
11. (k) Kline, T.; Bowman, J.; Iglewski, B. H.; De Kievit, T.; Kakai, Y.; Passador, L. Bioorg. Med. Chem. Lett. 1999, 9, 3447-3452;
12. Chem. Abstr. 132:217886.
13. Adams, J. L.; Gallapher T. F.; Boehm, J. C.; Thompson, S. M. PCT Int. Appl. WO 9513067, 1995; Chem. Abstr. 123:152881.
14. (a) McClure, K. F.; Abramov, Y. A.; Laird, E. R.; Barberia, J. T.; Cai, W.; Carty, T. J.; Cortina, S. R.; Danley, D. E.; Alan J. Dipesa, A. J.; Donahue, K. M.; Dombroski, M. A.; Elliott, N. C.; Gabel, C. A.; Han, S.; Hynes, T. R.; LeMotte, P. K.; Mansour, M. N.; Marr, E. S.; Letavic, M. A.; Pandit, J.; Ripin, D. B.; Sweeney, F. J.; Tan, D.; Tao, Y. J. Med. Chem. 2005, 48, 5728-5737.
15. (b) McClure, K. F.; Letavic, M. A.; Kalgutkar, A. S.; Gabel, C. A.; Audoly, L.; Barberia, J. T.; Braganza, J. F.; Carter, D.; Thomas, J.; Carty, T. J.; Cortina, S, R.; Dombroski, M. A.; Donahue, K. M.; Elliott, N. C.; Gibbons, C. P.; Jordan, C. K.; Kuperman, A. V.; Labasi, J. M.; LaLiberte, R. E.; McCoy, J. M.; Naiman, B. M.; Nelson, K. L.; Nguyen, H. T.; Peese, K. M.; Sweeney, F. J.; Taylor, T. J.; Trebino, C. E.; Abramov, Y. A.; Laird, E. R.; Volberg, W. A.; Zhou, J.; Bach, J.; Lombardo, F. Bioorg. Med. Chem. Lett. 2006, 16, 4339-4344.
16. (c) Buzon, R. A.; Castaldi, M. J.; Li, Z. B.; Ripin, D. H. B.; Tao, Y. PCT Int. Appl. WO 2004020438, 2004; Chem. Abstr. 140:235721.
17. (a) Doherty, J. B.; Stelmach, J. E.; Chen, M.-H. Expert Opin. Ther. Pat. 2003, 13, 381-385.
18. (b) Westra, J.; Doornbos-van der, M.; de Boer, P.; van Leeuwen, M. A.; van Rijswijk, M. H.; Limburg, P. C. Arthritis Res. Ther. 2004, 6, R384-R392.
19. (a) Sisko, J.; Mellinger, M.; Sheldrake, P. W.; Baine, N. H. Org. Synth. 2000, 77, 198-205.
20. (b) Sisko, J. U.S. Patent 6239279 B1, Appl. U.S. 98-212872; Chem. Abstr. 2001, 135, 5623.
21. (c) Adams, J. L.; Sheldrake, P. W.; Gallagher, T. F.; Garigipati, R.; Bender, P. E.; Boehm, J. C.; Sisko, J.; Peng, Z.-Q.; Lee, J. C. U.S. Patent 6103936, Appl. 08/819,619, 1996.
22. Van Leusen, A. M.; Hoogenboom, B. E.; Siderius, H. Tetrahedron Lett. 1972, 23, 2369-2372.
23. Preparation and handling of 4-fluorophenyl and 3,4-difluorophenyl tosylmethylisocyanides were considerably less problematic. See ref 3b.
24. (a) Baumann, M.; Baxendale, I. R.; Ley, S. V.; Smith, C. D.; Tranmer, G. K. Org. Lett. 2006, 8, 5231-5234.
25. (b) Davies, J. R.; Kane, P. D.; Moody, C. J. Tetrahedron 2004, 60, 3967-3977.
26. (c) Xia, Q.; Ganem, B. Synthesis 2002, 14, 1969-1972.
27. (d) Ohba, M.; Kubo, H.; Seto, S.; Fujii, T.; Ishibashi, H. Chem. Pharm. Bull. 1998, 46, 860-862.
28. (e) Matsumoto, K.; Suzuki, M.; Yoneda, N.; Miyoshi, M. Synthesis 1976, 12, 805-7.
29. (f) Theilig, G. Chem. Ber. 1953, 86, 96-109.
30. Vedejs, E.; Luchetta, L. M. J. Org. Chem. 1999, 64, 1011.
31. (a) Sisko, J.; Kassick, A. J.; Mellinger, M.; Filan, J. J.; Allen, A.; Olsen, M. A. J. Org. Chem. 2000, 65, 1516-1524.
32. (b) Sisko, Joseph; Mellinger, Mark; Sheldrake, Peter W.; Baine, Neil, H. Tetrahedron Lett. 1996, 37, 8113-8116.
33. Contaminated with <2% of the 2-bromoxazole 9 and <0.2% of the 2,4-dibromo 10.
34. Schroeder, R.; Schollkopf, U.; Blume, E.; Hoppe, I. Justus Liebigs Ann. Chem. 1975, 533.
35. Dondoni, A.; Fantin, G.; Fogagnolo, M.; Medici, A.; Pedrini, P. J. Org. Chem. 1987, 52, 3413-3420.
36. (a) Sarrif, A. M.; Krahn, D. F.; Donovan, S. M.; O'Neil, R. M. Mutat. Res. 1997, 380, 167-177.
37. (b) Ashby, J.; Styles, J. A.; Paton, D. Br. J. Cancer 1978, 38, 418-427.
38. Although the freezing point of DMF is -61 °C, the reaction mixture had a freezing point of < -70 °C.
39. Quenching the reaction at -15 °C with NBS led to a ca. 2/1 ratio of regioisomers, favoring the C-4 product. NBS was added as a solution in DMF (2.7 mL/g of NBS) at room temperature. Pre-cooling of the NBS solution would be desirable, but it reduced the solubility significantly. More studies are needed to determine if the anion quench can be adapted in a flow reactor under non-cryogenic conditions.
40. A trace amount (<1%) of the dibromide 10 was observed in the reaction but was purged during the isolation of 8.
41. (a) Some examples of palladium purging methods: Welch, C. J.; Albaneze-Walker, J.; Leonard, W. R.; Biba, M.; DaSilva, J.; Henderson, D.; Laing, B.; Mathre, D. J.; Spencer, S.; Bu, X.; Wang, T. Org. Process Res. Dev. 2005, 9, 198-205.
42. (b) Koenigsberger, K.; Chen, G.-P.; Wu, R. R.; Girgis, M. J.; Prasad, K.; Repic, O.; Blacklock, T. J. Org. Process Res. Dev. 2003, 7, 733-742.
43. (c) Chen, C.-Y.; Dagneau, P.; Grabowski, E. J. J.; Oballa, R.; O'Shea, P.; Prasit, P.; Robichaud, J.; Tillyer, R.; Wang, X. J. Org. Chem. 2003, 68, 2633-2638.
44. (d) Urawa, Y.; Miyazawa, M.; Ozeki, N.; Ogura, K. Org. Process Res. Dev. 2003, 7, 191-195.
45. (e) Ishihara, K.; Nakayama, M.; Kurihara, H.; Itoh, A.; Haraguchi, H. Chem. Lett. 2000, 10, 1218-1219.
46. (f) Rosso, V. W.; Lust, D. A.; Bernot, P. J.; Grosso, J. A.; Modi, S. P.; Rusowicz, A.; Sedergran, T. C.; Simpson, J. H.; Srivastava, S. K.; Humora, M. J.; Anderson, N. G. Org. Process Res. Dev. 1997, 1, 311-314.